Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

Autor: Fahal, Ahmed H *, Ahmed, Eiman Siddig, Bakhiet, Sahar Mubarak, Bakhiet, Osama Elhadi, Fahal, Lamis Ahmed, Mohamed, Abubakar Ahmed, Mohamedelamin, El Semani Widaa, Bahar, Mustafa El Nour, Attalla, Hadil Yassir, Siddig, Emmanuel Edwar, Mhmoud, Najwa A, Musa, Ahmed Mudawi, van de Sande, Wendy W J, Scherrer, Bruno, Oyieko, Peelen, Egondi, Thaddaeus W, Onyango, Kevin O, Hata, Katsura, Chu, Wan-Yu, Dorlo, Thomas P C, Brüggemann, Roger J, Nyaoke, Borna A, Strub-Wourgaft, Nathalie *, Zijlstra, Eduard E *
Zdroj: In The Lancet Infectious Diseases November 2024 24(11):1254-1265
Databáze: ScienceDirect